The primary focus of Dr. Sahel's laboratory and clinical investigations is to understand the mechanisms associated with retinal degeneration to develop vision restoration therapies. He conducts research on vision restoration focusing on cellular and molecular mechanisms underlying retinal degeneration, and development of treatments for currently untreatable retinal diseases.
Founded by Leah Byrne, PhD, Assistant Professor of Ophthalmology, Avista Therapeutics develops innovative gene therapies for retinal diseases, including rare ophthalmic conditions that have a profound impact on quality of life.
Dr. Martel's research and clinical activities are focused on investigating and treating patients with vision-threatening vitreoretinal diseases with specific interest and expertise in vision restoration therapies, retinal prosthetic devices, and robotic-assisted vitreoretinal surgery.
Dr. Rosin's research is focused on studying the visual signal processing in the CNS of various animal models of IRDs. His laboratory collaborates with many other laboratories at the Vision Institute, providing functional assessment of visual function and functional vision in animal models visual disorders.